227 related articles for article (PubMed ID: 7514042)
1. Continuing development of acid pump inhibitors: site of action of pantoprazole.
Shin JM; Besancon M; Prinz C; Simon A; Sachs G
Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
[TBL] [Abstract][Full Text] [Related]
2. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
Besancon M; Simon A; Sachs G; Shin JM
J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
[TBL] [Abstract][Full Text] [Related]
3. [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
Morozov IA
Eksp Klin Gastroenterol; 2002; (3):94-100, 122. PubMed ID: 12353402
[TBL] [Abstract][Full Text] [Related]
4. Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
Metz DC; Ferron GM; Paul J; Turner MB; Soffer E; Pisegna JR; Bochenek WJ
J Clin Pharmacol; 2002 May; 42(5):512-9. PubMed ID: 12017345
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of gastric acid inhibition.
Shamburek RD; Schubert ML
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):23-54. PubMed ID: 8097411
[TBL] [Abstract][Full Text] [Related]
6. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
7. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
8. Acid secretion and the H,K ATPase of stomach.
Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
[TBL] [Abstract][Full Text] [Related]
9. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.
Londong W
Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293
[TBL] [Abstract][Full Text] [Related]
10. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
Shin JM; Sachs G
Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological aspects of acid secretion.
Hirschowitz BI; Keeling D; Lewin M; Okabe S; Parsons M; Sewing K; Wallmark B; Sachs G
Dig Dis Sci; 1995 Feb; 40(2 Suppl):3S-23S. PubMed ID: 7859583
[TBL] [Abstract][Full Text] [Related]
12. Physiology of the parietal cell and therapeutic implications.
Sachs G
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):68S-73S. PubMed ID: 14587960
[TBL] [Abstract][Full Text] [Related]
13. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation.
Bakke I; Qvigstad G; Brenna E; Sandvik AK; Waldum HL
Acta Physiol Scand; 2000 May; 169(1):29-37. PubMed ID: 10759608
[TBL] [Abstract][Full Text] [Related]
14. Role of pantoprazole in the treatment of gastro-oesophageal reflux disease.
Lehmann FS; Beglinger C
Expert Opin Pharmacother; 2005 Jan; 6(1):93-104. PubMed ID: 15709887
[TBL] [Abstract][Full Text] [Related]
15. Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats.
Zhao CM; Bakke I; Tostrup-Skogaker N; Waldum HL; Håkanson R; Chen D
Cell Tissue Res; 2001 Mar; 303(3):415-22. PubMed ID: 11320657
[TBL] [Abstract][Full Text] [Related]
16. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole.
Huber R; Kohl B; Sachs G; Senn-Bilfinger J; Simon WA; Sturm E
Aliment Pharmacol Ther; 1995 Aug; 9(4):363-78. PubMed ID: 8527612
[TBL] [Abstract][Full Text] [Related]
17. Restoration of acid secretion following treatment with proton pump inhibitors.
Shin JM; Sachs G
Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
[TBL] [Abstract][Full Text] [Related]
18. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
[TBL] [Abstract][Full Text] [Related]
19. The site of action of pantoprazole in the gastric H+/K(+)-ATPase.
Shin JM; Besancon M; Simon A; Sachs G
Biochim Biophys Acta; 1993 Jun; 1148(2):223-33. PubMed ID: 8389196
[TBL] [Abstract][Full Text] [Related]
20. The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
Postius S; Bräuer U; Kromer W
Life Sci; 1991; 49(14):1047-52. PubMed ID: 1832475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]